Home » Stocks » CFMS

Conformis, Inc. (CFMS)

Stock Price: $1.45 USD -0.01 (-0.68%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
Market Cap 266.41M
Revenue (ttm) 66.12M
Net Income (ttm) -26.45M
Shares Out 182.48M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $1.45
Previous Close $1.46
Change ($) -0.01
Change (%) -0.68%
Day's Open 1.47
Day's Range 1.44 - 1.54
Day's Volume 4,441,973
52-Week Range 0.60 - 1.56

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Which penny stocks are investors watching with August only a week away? The post Best Penny Stocks to Buy in August?

Other stocks mentioned: ACST, HMY, NAK
5 days ago - PennyStocks

Looking For the Best Penny Stocks to Watch in July? Check These 4 Out The post Penny Stocks to Buy Right Now?

Other stocks mentioned: ARPO, DPW, INVU
1 week ago - PennyStocks

Which Tech Penny Stocks Are on Your July 2021 Watchlist? The post Best Tech Penny Stocks to Buy in 2021?

Other stocks mentioned: ENZC, IDEX
1 week ago - PennyStocks

BILLERICA, Mass., July 14, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today tha...

2 weeks ago - GlobeNewsWire

Conformis Settles Wright Medical Litigation Related to Patient-Specific Instruments for Use with Shoulder Implants Conformis Settles Wright Medical Litigation Related to Patient-Specific Instruments for...

3 weeks ago - GlobeNewsWire

BILLERICA, Mass., July 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the second quarter ended June 30, 2021 after the market ...

4 weeks ago - GlobeNewsWire

Penny stocks offer a lot of risk balanced by lots of reward. Here are 7 that could surge in price and which have reasonable catalysts behind them.

Other stocks mentioned: ELYS, MNMD, NXE, PTIX, SENS, SESN
1 month ago - InvestorPlace

New Agreement expands Conformis' global reach and brings patient-specific knee replacement systems to the largest market in the Asia-Pacific region New Agreement expands Conformis' global reach and brin...

1 month ago - GlobeNewsWire

In a recent pennystocks.com article, we covered 5 Penny Stocks on Reddit for Your June 2021 Watchlist. This piece is a continuation, as more and more valuable penny stocks continue to come to light. Rig...

Other stocks mentioned: BOXL, CLSD, PTIX, UXIN
1 month ago - PennyStocks

Looking for penny stocks to buy on Reddit? Check these 4 out for your watchlist The post 4 Penny Stocks Reddit Traders Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Informa...

Other stocks mentioned: CLSD, OBLN, TELL
1 month ago - PennyStocks

BILLERICA, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that...

2 months ago - GlobeNewsWire

BILLERICA, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that...

2 months ago - GlobeNewsWire

These penny stocks just released big news; will they be on your watchlist? The post Best Penny Stocks to Buy?

Other stocks mentioned: HRVSF, PTE
2 months ago - PennyStocks

Leveraging Conformis' extensive library of personalized knee design data and patient images, Identity Imprint is designed to match patients' anatomy with an optimal arthroplasty solution while at the sa...

2 months ago - GlobeNewsWire

ConforMIS (CFMS) delivered earnings and revenue surprises of -12.50% and -0.29%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of Conformis (NASDAQ:CFMS) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 35.71% year over year to ($0.09), which missed the esti...

2 months ago - Benzinga

BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today finan...

2 months ago - GlobeNewsWire

Conformis (NASDAQ:CFMS) unveils its next round of earnings this Wednesday, May 05. Here is Benzinga's everything-that-matters guide for the earnings announcement.

2 months ago - Benzinga

ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Creating a penny stock watchlist? You should check these 3 out The post Best Penny Stocks to Buy?

Other stocks mentioned: JAGX, ZOM
3 months ago - PennyStocks

BILLERICA, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received 510(k) clearance by the U.S. Food and Drug Administration for patient-specific instrum...

3 months ago - GlobeNewsWire

Here are five orthopedic device stocks, Integra (IART), Conformis (CFMS), SeaSpine (SPNE), Zimmer Biomet (ZBH), Orthofix (OFIX), which are expected to continue their run over the next few months.

Other stocks mentioned: IART, NUVA, OFIX, SPNE, ZBH
3 months ago - Zacks Investment Research

Commercial Interest in Accurate, Disposable, Patient-Specific Instrumentation Continues to Expand Commercial Interest in Accurate, Disposable, Patient-Specific Instrumentation Continues to Expand

3 months ago - GlobeNewsWire

BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the market...

3 months ago - GlobeNewsWire

Independent, retrospective review of 2016-2019 surgeon data by University of Washington researchers demonstrates that Conformis iTotal® knee replacement implants enable expedited surgical time and reduc...

4 months ago - GlobeNewsWire

ConforMIS (CFMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

4 months ago - Zacks Investment Research

ConforMIS (CFMS) delivered earnings and revenue surprises of 27.27% and -0.08%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

4 months ago - Zacks Investment Research

BILLERICA, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the fourth quarter and year ended December 31, 2020.

4 months ago - GlobeNewsWire

Shares of ConforMIS (NASDAQ: CFMS) traded up as high as 37% in Tuesday's pre-market trading session. The company released a press release stating that the Therapeutic Goods Administration, part of the A...

4 months ago - Benzinga

On Wednesday, March 03, Conformis (NASDAQ:CFMS) will release its latest earnings report. Decipher the announcement with Benzinga's help.

4 months ago - Benzinga

CFMS stock is jumping as Conformis preps to introduce a knee replacement system in Australia. Here's what you should know.

4 months ago - InvestorPlace

The iTotal® PS total knee replacement system is designed so that its patient-specific implants fit the unique size and shape of each patient's knee, and provide optimal stability throughout the full ran...

4 months ago - GlobeNewsWire

BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an offering p...

5 months ago - GlobeNewsWire

BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis inten...

5 months ago - GlobeNewsWire

BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical device te...

6 months ago - GlobeNewsWire

Conformis (CFMS) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

6 months ago - Zacks Investment Research

BILLERICA, Mass., Dec. 31, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation and implants, announced today that Mark Augusti, Chief Execu...

6 months ago - GlobeNewsWire

Cordera™ Match Hip System combines the proven Cordera™ hip stem with Conformis' state-of-the-art, personalized pre-operative plans and patient-specific instruments. Cordera™ Match Hip System combines th...

7 months ago - GlobeNewsWire

BILLERICA, Mass., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer, will...

8 months ago - GlobeNewsWire

BILLERICA, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Bart Lagae as its new VP, International Sales & Marketing.

8 months ago - GlobeNewsWire

Conformis's (CFMS) CEO Mark Augusti on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

ConforMIS (CFMS) delivered earnings and revenue surprises of 25.00% and 0.13%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

BILLERICA, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the third quarter ended September 30, 2020.

8 months ago - GlobeNewsWire

Conformis (NASDAQ: CFMS) releases its next round of earnings this Wednesday, November 04. Get the latest predictions in Benzinga's essential guide to the company's Q3 earnings report.

8 months ago - Benzinga

BILLERICA, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer, will...

9 months ago - GlobeNewsWire

ConforMIS (CFMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

Earnings Call to be Hosted on November 4, 2020 Earnings Call to be Hosted on November 4, 2020

9 months ago - GlobeNewsWire

Cordera™ Hip System with optional patient-specific instrumentation and personalized surgical plan joins the 3D Conformis Hip System as the latest hip technology from Conformis Cordera™ Hip System with o...

10 months ago - GlobeNewsWire

BILLERICA, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive agreement with a healthcare focused institutional investor to sell ...

10 months ago - GlobeNewsWire

BILLERICA, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) will participate in the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit being held September 21-23, 2...

10 months ago - GlobeNewsWire

About CFMS

Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee; and iTotal Identity, a knee system. It also provides Conformis Hip System and Cordera h... [Read more...]

Industry
Medical Devices
IPO Date
Jul 1, 2015
Stock Exchange
NASDAQ
Ticker Symbol
CFMS
Full Company Profile

Financial Performance

In 2020, Conformis's revenue was $68.76 million, a decrease of -11.19% compared to the previous year's $77.43 million. Losses were -$24.29 million, -14.70% less than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for Conformis stock is "Buy." The 12-month stock price forecast is 2.33, which is an increase of 60.69% from the latest price.

Price Target
$2.33
(60.69% upside)
Analyst Consensus: Buy